The University of Maryland Marlene and Stewart Greenebaum Cancer Center's physicians and researchers work every day to advance the state-of-the-art in cancer treatment.
Their groundbreaking work in the cancer center's laboratories and clinics has contributed to the discovery of new ways to treat and care for cancer patients.
To learn about some of the recent news-making advances in cancer research and treatment at UMGCC during 2008, select from and click on the news stories below.
2008 News Releases
|12/16||University of Maryland School of Medicine Recruits Curt I. Civin, MD, to Lead New Stem Cell Research Center|
|11/25||American Cancer Society Awards $360,000 Grant to University of Maryland Greenebaum Cancer Center|
|9/24||University of Maryland Medical Center Named as One of Nation's Top Hospitals for Safety and Quality, Third Year in a Row|
|9/3||University of Maryland Greenebaum Cancer Center Receives Prestigious National Cancer Institute Designation|
|7/14||African-American Community, Some Rural Areas in Maryland Underrepresented in Federally Funded Cancer Treatment Trials|
|5/28||Nurses Torr and Sumter are First to Win New Greenebaum Compassion Award|
|5/5||University of Maryland's Baltimore City Cancer Program Receives $420,000 from Avon Foundation|
|3/4||Adding Gemcitabine to Standard Therapy After Surgery Improves Survival for Patients with Pancreatic Cancer|
|1/17||UMGCC Applies for NCI Cancer Center Designation|
|Click here to see the 2007 news release archives.|